Just quickly and off the top of my head, I thought AVX had agreed a much quicker and less expensive route to market with the FDA meaning that the Phase 3 trials were significantly cheaper to fund than previously expected?
AVX Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held